Sign In
Get Clay Free →

Suggestions

    Robert Gellibolian

    Founder and Chief Executive Officer at CellectGen, Inc.

    Robert Gellibolian is the Founder & CEO of CellectGen, a digital health technology company specializing in developing saliva-based, consumer-facing next generation point-of-care (POC) tests, devices, and services.

    CellectGen aims to empower consumers to easily monitor and track their health status in less than 15 minutes using Artificial Intelligence-enabled diagnostic test platforms.

    Their first product is a POC, saliva-based test designed to accurately identify early signs of gum disease, a condition that impacts millions of Americans.

    Robert's education includes postdoctoral studies in Oncology and Cancer Biology at Salk Institute for Biological Studies, a B.S. in Biochemistry from the University of California, Los Angeles, and a Ph.D. in Biochemistry, Biophysics, and Molecular Biology from Texas A&M University.

    Throughout his career, Robert has held various roles such as Principal at Startup Advisor, Entrepreneur In Residence at Children's Hospital Los Angeles, Clinical Associate Professor at the University of Southern California, Founder & Chief Consultant at PhD Nootrition, among others.

    He has also been involved in organizations like CellectGen, Inc., N-Abl THERAPEUTICS, INC., FLOZ, and various roles in research and development at leading institutions like the Salk Institute and Agilent Technologies.

    Robert Gellibolian's work focuses on leveraging technology to improve healthcare accessibility and early disease detection through innovative saliva-based testing solutions.

    Robert Gellibolian
    Add to my network

    Location

    Pasadena, California